OpenAlex
PricingAboutJobs
Log inGet started
Work

Tivozanib, a pan-VEGFR tyrosine kinase inhibitor for the potential treatment of solid tumors.

PubMed

Year: 2010
Type: article
Source: PubMed
Authors: Antonella De Luca, Nicola Normanno
Institution: Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Language: English

Topic: Angiogenesis and VEGF in Cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: tivozanib, VEGFR inhibitors, VEGFR1, VEGFR2, VEGFR-3, renal cell carcinoma, angiogenesis inhibition, solid tumors, anticancer activity, adverse events, hypertension, dysphonia, sorafenib comparison, breast cancer, lung cancer, colorectal cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W120231122
FWCI: 2.255
Cites:
Cited by: 57
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security